Premium
Burden of primary influenza and respiratory syncytial virus pneumonia in hospitalised adults: insights from a 2‐year multi‐centre cohort study (2017–2018)
Author(s) -
Boattini Matteo,
Charrier Lorena,
Almeida André,
Christaki Eirini,
Moreira Marques Torcato,
Tosatto Valentina,
Bianco Gabriele,
Iannaccone Marco,
Tsiolakkis Georgios,
Karagiannis Christos,
Maikanti Panagiota,
Cruz Lourenço,
Antão Diogo,
Moreira Maria Inês,
Cavallo Rossana,
Costa Cristina
Publication year - 2023
Publication title -
internal medicine journal
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.596
H-Index - 70
eISSN - 1445-5994
pISSN - 1444-0903
DOI - 10.1111/imj.15583
Subject(s) - medicine , pneumonia , cohort , respiratory system , cohort study , virus , influenza a virus , pediatrics , virology , intensive care medicine , emergency medicine
Background Viral community‐acquired pneumonia (CAP) is a potentially serious illness, particularly in adult patients with underlying chronic conditions. In addition to the most recent SARS‐CoV‐2, influenza, and respiratory syncytial virus (RSV) are considered the most relevant causes of viral CAP. Aims To describe the clinical features of hospitalised adults admitted for influenza‐A/B and RSV pneumonia and analyse, according to aetiology, factors associated with non‐invasive ventilation (NIV) failure and in‐hospital death (IHD). Methods This was a retrospective and multi‐centre study of all adults who were admitted for laboratory‐confirmed influenza‐A/B or RSV pneumonia, during two consecutive winter seasons (October–April 2017–2018 and 2018–2019) in three tertiary hospitals in Portugal, Italy and Cyprus. Results A total of 356 adults were included in the study. Influenza‐A, influenza‐B and RSV were deemed to cause pneumonia in 197 (55.3%), 85 (23.9%) and 74 (20.8%) patients, respectively. Patients with both obstructive sleep apnoea or obesity hypoventilation syndrome and influenza‐A virus pneumonia showed a higher risk for NIV failure (odds ratio (OR) 4.66; 95% confidence interval (CI) 1.42–15.30). Patients submitted to NIV showed a higher risk for IHD, regardless of comorbidities (influenza‐A OR 3.00; 95% CI 1.35–6.65, influenza‐B OR 4.52; 95% CI 1.13–18.01, RSV OR 5.61; 95% CI 1.26–24.93). Conclusion The increased knowledge of influenza‐A/B and RSV pneumonia burden may contribute to a better management of patients with viral CAP.